Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Leif Sander and Elisa Helbig.
Leif Sander
Connection Strength
0.537
Elisa Helbig
  1. Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study. Lancet Respir Med. 2021 11; 9(11):1255-1265.
    View in: PubMed
    Score: 0.240
  2. Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective observational study. Clin Microbiol Infect. 2021 Oct; 27(10):1520.e7-1520.e10.
    View in: PubMed
    Score: 0.059
  3. A time-resolved proteomic and prognostic map of COVID-19. Cell Syst. 2021 08 18; 12(8):780-794.e7.
    View in: PubMed
    Score: 0.059
  4. Delayed Antibody and T-Cell Response to BNT162b2 Vaccination in the Elderly, Germany. Emerg Infect Dis. 2021 08; 27(8):2174-2178.
    View in: PubMed
    Score: 0.059
  5. Outbreak of SARS-CoV-2 B.1.1.7 Lineage after Vaccination in Long-Term Care Facility, Germany, February-March 2021. Emerg Infect Dis. 2021 08; 27(8):2169-2173.
    View in: PubMed
    Score: 0.059
  6. Clinical and virological characteristics of hospitalised COVID-19 patients in a German tertiary care centre during the first wave of the SARS-CoV-2 pandemic: a prospective observational study. Infection. 2021 Aug; 49(4):703-714.
    View in: PubMed
    Score: 0.059
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.